跳至主要内容
临床试验/NCT02613923
NCT02613923已完成不适用

A Pilot Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer

Case Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2015年8月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Difference in change in Insomnia Severity Index (ISI) score between groups

研究概览

简要总结

Participants are asked to participate in a research study of the effect of a sleep intervention on improving sleep habits and reducing their risk of breast cancer.

Participants are asked to participate in this research study because they have been identified as being at higher than average risk of developing breast cancer.

The purpose of this study is to compare women who get a sleep intervention to women who do not get a sleep intervention. This study team will compare these two groups of women to see if the sleep intervention improves their sleep and if it lowers markers of inflammation that have been associated with an increased risk of breast cancer.

详细描述

Objective 1: To test the effectiveness of the GO! To Sleep program at improving the sleep duration and sleep quality in women at high risk of breast cancer.

Objective 2: To test the effectiveness of improvements in sleep quality and/or duration due to the GO! To Sleep program on biomarkers of inflammation in women at high risk of breast cancer.

Objective 3: To evaluate the effectiveness of improvements in health-related quality of life after the GO! To Sleep in women at high risk of breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women at high risk of breast cancer due to one or more of the following:
  • Carry deleterious mutations in the BRCA1, BRCA2, PTEN, TP53, STK11, or CDH1 genes
  • Previous diagnosis of lobular carcinoma in situ (LCIS), atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH)
  • Lifetime risk of 20% or greater as calculated by the National Cancer Institute (NCI) Breast Cancer Risk Assessment Tool or the Tyrer-Cuzick IBIS Risk Assessment Tool
  • Ability to access the internet and watch videos online.
  • Valid email address.
  • Self-reported sleep duration of 6 hours per night or less

排除标准

  • Previous diagnosis of cancer.
  • Lack of ability to read and converse in English.
  • Lack of ability to give informed consent.

研究组 & 干预措施

GO! To Sleep

Experimental

Participants in the intervention group will be provided with a code and website address to participate in this program. This program includes reminder emails and is 6 weeks in duration. Participants will be given a blood draw to measure biomarkers.

干预措施: GO! To Sleep (Behavioral)

GO! To Sleep

Experimental

Participants in the intervention group will be provided with a code and website address to participate in this program. This program includes reminder emails and is 6 weeks in duration. Participants will be given a blood draw to measure biomarkers.

干预措施: Blood Draw (Procedure)

GO! To Sleep

Experimental

Participants in the intervention group will be provided with a code and website address to participate in this program. This program includes reminder emails and is 6 weeks in duration. Participants will be given a blood draw to measure biomarkers.

干预措施: Pittsburgh Sleep Quality Index (PSQI) (Other)

GO! To Sleep

Experimental

Participants in the intervention group will be provided with a code and website address to participate in this program. This program includes reminder emails and is 6 weeks in duration. Participants will be given a blood draw to measure biomarkers.

干预措施: Insomnia Severity Index (ISI) (Other)

GO! To Sleep

Experimental

Participants in the intervention group will be provided with a code and website address to participate in this program. This program includes reminder emails and is 6 weeks in duration. Participants will be given a blood draw to measure biomarkers.

干预措施: SF-12 quality of life survey (Other)

informational control

Active Comparator

Participants in the control group will receive weekly emails with sleep information and the health benefits of sleep for 6 weeks.Participants will be given a blood draw to measure biomarkers.

干预措施: Sleep information (Behavioral)

informational control

Active Comparator

Participants in the control group will receive weekly emails with sleep information and the health benefits of sleep for 6 weeks.Participants will be given a blood draw to measure biomarkers.

干预措施: Blood Draw (Procedure)

informational control

Active Comparator

Participants in the control group will receive weekly emails with sleep information and the health benefits of sleep for 6 weeks.Participants will be given a blood draw to measure biomarkers.

干预措施: Pittsburgh Sleep Quality Index (PSQI) (Other)

informational control

Active Comparator

Participants in the control group will receive weekly emails with sleep information and the health benefits of sleep for 6 weeks.Participants will be given a blood draw to measure biomarkers.

干预措施: Insomnia Severity Index (ISI) (Other)

informational control

Active Comparator

Participants in the control group will receive weekly emails with sleep information and the health benefits of sleep for 6 weeks.Participants will be given a blood draw to measure biomarkers.

干预措施: SF-12 quality of life survey (Other)

结局指标

主要结局

Difference in change in Insomnia Severity Index (ISI) score between groups

时间窗: Change from baseline to post intervention, around 8 weeks after baseline

Sleep quality will be measured with the insomnia severity index (ISI). A validated instrument for sleep quality

Difference in change in sleep duration between groups

时间窗: Change from baseline to post intervention, around 8 weeks after baseline

Sleep duration will be obtained by self-report from responses to the PSQI

Difference in Change in Pittsburgh Sleep Quality Index (PSQI) score between groups

时间窗: Change from baseline to post intervention, around 8 weeks after baseline

Sleep quality will be measured by the PSQI which is a continuous measure from 0 (best) to 21 (worst)

次要结局

  • Difference in change of SF-12 score from baseline to post-intervention between groups(Change from baseline to 6 months post intervention)
  • Correlation of joint changes in biomarker levels with PSQI and ISI(Change from baseline to 6 months post intervention)
  • Difference in change in Insomnia Severity Index (ISI) score between groups(Change from baseline to 6 months post intervention)
  • Difference in Change in Pittsburgh Sleep Quality Index (PSQI) score between groups(Change from baseline to 6 months post intervention)
  • Difference in change in sleep duration between groups(Change from baseline to 6 months post intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验